HILAR CHOLANGIOCARCINOMA
Clinical trials for HILAR CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HILAR CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for HILAR CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple therapy shrinks bile duct tumors, may enable surgery
Disease control Recruiting nowThis phase II trial tests a combination of immunotherapy (tislelizumab), chemotherapy (gemcitabine plus cisplatin or oxaliplatin), and targeted radiation before possible surgery in 38 people with hilar cholangiocarcinoma that is borderline or not removable. The goal is to see if …
Matched conditions: HILAR CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Simple blood test could spot deadly bile duct cancers earlier
Diagnosis Recruiting nowThis study is testing a blood test that looks for DNA changes from tumors to help diagnose and manage biliary tract cancers, which are often found late and have a low survival rate. Researchers will enroll 1,800 participants with confirmed cancers to see how accurate the test is.…
Matched conditions: HILAR CHOLANGIOCARCINOMA
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated Jun 26, 2026 18:38 UTC